Chemours Company (The) (NYSE:CC) has a 1 Year Target Estimate of $21.43. The stock traded with the volume of 2.67 Million in the last trading session. Chemours Company (The) opened at $22.9 and closed by showing an increase of 3.82%. The Bid price in the last session was $22.48 x 500 and the Ask price was $23.69 x 300. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).
Chemours Company (The) has the Market Capitalization of 4.29 Billion. The Stock has its 52-week High of $23.9 and 52-Week Low of $3.06 and it touched its 52-week high on Nov 23, 2016 and 52-Week Low on Jan 27, 2016.
Chemours Company (The) reported its last Earnings on Nov 07 BMO where the company reported Actual EPS of $0.61/Share whereas, the Analyst Estimated EPS was $0.34/share. The difference between Actual EPS and Estimated EPS was $0.27/share. This represented an Earnings Surprise of 79.4%.
7 number of analysts also provided their insight on Chemours Company (The), where the Average Price Target for the stock is $21.43. They also projected Low Price Target as $13 while High Price Target is set at $25.
A number of analysts rated the stock as well: 0 analysts believe that the stock is a STRONG BUY while 0 reported it as Buy.0 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.
Chemours Company (The) annual Divided is 0.12 while it’s Dividend Yield is 0.51%. The stock has its Price to Earnings (P/E) ratio of 28.88 and Forward Price to Earnings ratio of 13.06. The company has its Price to Sales (P/S) ratio of 0.79 where Price to Book (P/B) ratio of 11.36, Price to Cash Per share (P/C) of 4.49 and Price to Free Cash Flow (P/FCF) has a value of 17.68.
The company has its Return on Assets (ROA) of 2.4 Percent. Return on Equity (ROE) stands at 70.6% and Return on Investment (ROI) displays a value of -0.8%.
The stock is currently trading at Distance from 20-Day simple moving Average of 14.71% whereas, Distance from 50-Day Simple moving average is 34.02 Percent and Distance from 200-Day Simple Moving Average of 113.06 percent.
A look at performance overview of Chemours Company (The) depicts that Performance (Week) is 1.64 percent while Performance Month is 35.09%. Quarterly performance shows a value of 76.78% and Half Year Performance value stands at 169.5%. Yearly performance of the stock has the value of 282.5 percent. Chemours Company (The) has its YTD performance of 346.01 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).
Many Insiders have done trades inside the company. The latest trade was made on 10 Nov 2016 where Chief Financial Officer Newman (Mark) did a transaction type “Sell” in which 10544 shares were traded at a price of $20.71. Another insider trade includes Officer Albright (Elizabeth) who also initiated a transaction in which 8445 shares were traded on 26 Oct 2016 as “Sell”. On 29 Jun 2016 Officer Trojanowski (Amy) traded 43 shares as “Sell” at $8.24. Director Brown (Richard H) Sell 10528 shares on 29 Jun 2016 at the price of $8.24.
The latest Upgrades/Downgrades was done by Research firm Goldman on 14-Mar-16 who Upgrade the stock from Neutral to Buy. Other firms have also Upgraded/Downgraded the stock. On 16-Feb-16, Jefferies took an action “Downgrade” from Buy to Hold. On 18-Sep-15, the stock was Initiated to Hold by Argus.